Overview
Myelin Therapeutics is a clinical-stage biotech developing gene therapies targeting myelin repair and remyelination for patients with multiple sclerosis and related demyelinating diseases.
More in Neuropharmaceuticals
Latest industry news
Implanted BCIs Restore Expressive Communication for Paralyzed Clinical Trial Participants
2026-11-15 · Research
Synchron Halts BCI Trials After Device Falls Short of Performance Benchmarks
2026-11-14 · Industry
China's Brain-Computer Interface Sector Enters Clinical Reality With First Commercial Implants
2026-11-13 · Industry
Synchron Pauses Brain Implant Trials After Performance Issues Surface
2026-11-12 · Industry
Company details
Category
💊 Neuropharmaceuticals
Location
Cambridge, MA
Funding
Series A — $28M
Website
myelintherapeutics.comListed
2026-10-26
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →